GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES
Condition(s):Pancreatic AdenocarcinomaLast Updated:March 13, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Pancreatic AdenocarcinomaLast Updated:March 13, 2024Enrolling by invitation
Condition(s):Hepatocellular Carcinoma Recurrent; Liver Transplant; ComplicationsLast Updated:June 24, 2021Unknown status
Condition(s):KRAS NP_004976.2:p.G12R; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7Last Updated:February 9, 2021Completed
Condition(s):Advanced / Metastic Solid Tumors; Glioblastoma; Chronic Leukemia LymphocyticLast Updated:July 5, 2022Recruiting
Condition(s):Head and Neck Neoplasms; Carcinoma, SquamousLast Updated:January 22, 2024Not yet recruiting
Condition(s):Prostate CancerLast Updated:January 4, 2022Recruiting
Condition(s):Periampullary Adenocarcinoma; Periampullary Cancer; Pancreatic CancerLast Updated:April 22, 2022Recruiting
Condition(s):Ovarian CancerLast Updated:December 7, 2022Recruiting
Condition(s):HER2-positive Breast CancerLast Updated:September 30, 2022Not yet recruiting
Condition(s):Adult GlioblastomaLast Updated:December 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.